Pioneering doctor reflects on gene therapy’s trajectory

November 23, 2016

Alessandra Biffi

“There were a lot of expectations 20 years ago, then there was a big drop related to side effects,” Alessandra Biffi, MD, director of gene therapy at Dana-Farber/Boston Children’s, tells New Scientist.

“Now everybody is again climbing to the top of the hill. But whether there is too much or too little enthusiasm doesn’t change the fact that development of gene therapy as a treatment is a process.”

Media Inquiries

Ellen Berlin
617-632-5357
ellen_berlin@dfci.harvard.edu

Kristen Dattoli
617-919-3141
kristen.dattoli@childrens.harvard.edu

Follow Us!

Our Twitter handle is:

Twitter Logo